CAR T Cells in Advanced R/R Lymphoma: Keeping Patients Alive CAR T Cells in Advanced R/R Lymphoma: Keeping Patients Alive

New longer-term data on CAR T cells in patients with refractory and relapsed (R/R) lymphoma show that responses are durable, with about half of patients alive after a year or more.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news